Effect of Bumetanide, a Selective Nkcc1 Inhibitor, on Hallucinations of Schizophrenic Patients; a Double-Blind Randomized Clinical Trial

Effect of Bumetanide, a Selective Nkcc1 Inhibitor, on Hallucinations of Schizophrenic Patients; a Double-Blind Randomized Clinical Trial Publisher Pubmed

Rahmanzadeh R¹ ; Eftekhari S² ; Shahbazi A² ; Khodaei Ardakani MR³ ; Rahmanzade R¹ ; Mehrabi S¹ ; Barati M¹ ; Joghataei MT¹

Show Affiliations

1. Division of Neuroscience, Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran
2. Faculty of Advanced Technologies in Medicine, Department of Neuroscience, Iran University of Medical Sciences, Tehran, Iran
3. Razi Psychiatric Hospital, University of Social Welfare and Rehabilitation, Tehran, Iran

Source: Schizophrenia Research Published:2017

Abstract

[No abstract available]

2. Long-Term Bumetanide Administration Altered Behavioral Pattern in Mosaic Down’S Syndrome: A Case Report, Applied Neuropsychology: Child (2023)

3. Longitudinal Effects of Bumetanide on Neuro-Cognitive Functioning in Drug-Resistant Epilepsy, Frontiers in Neurology (2019)

Experts (# of related papers)

View all Related Experts

Mahmoud Reza Hadjighassem (2)

Esmaeil Shahsavand Ananloo (1)

Style	Citing Format
MLA	Rahmanzadeh R, et al.. "Effect of Bumetanide, a Selective Nkcc1 Inhibitor, on Hallucinations of Schizophrenic Patients; a Double-Blind Randomized Clinical Trial." Schizophrenia Research, vol. 184, no. , 2017, pp. 145-146.
APA	Rahmanzadeh R, Eftekhari S, Shahbazi A, Khodaei Ardakani MR, Rahmanzade R, Mehrabi S, Barati M, Joghataei MT (2017). Effect of Bumetanide, a Selective Nkcc1 Inhibitor, on Hallucinations of Schizophrenic Patients; a Double-Blind Randomized Clinical Trial. Schizophrenia Research, 184(), 145-146.
Chicago	Rahmanzadeh R, Eftekhari S, Shahbazi A, Khodaei Ardakani MR, Rahmanzade R, Mehrabi S, Barati M, Joghataei MT. "Effect of Bumetanide, a Selective Nkcc1 Inhibitor, on Hallucinations of Schizophrenic Patients; a Double-Blind Randomized Clinical Trial." Schizophrenia Research 184, no. (2017): 145-146.
Harvard	Rahmanzadeh R et al. (2017) 'Effect of Bumetanide, a Selective Nkcc1 Inhibitor, on Hallucinations of Schizophrenic Patients; a Double-Blind Randomized Clinical Trial', Schizophrenia Research, 184(), pp. 145-146.
Vancouver	Rahmanzadeh R, Eftekhari S, Shahbazi A, Khodaei Ardakani MR, Rahmanzade R, Mehrabi S, et al.. Effect of Bumetanide, a Selective Nkcc1 Inhibitor, on Hallucinations of Schizophrenic Patients; a Double-Blind Randomized Clinical Trial. Schizophrenia Research. 2017;184():145-146.
BibTex	@article{ author = {Rahmanzadeh R and Eftekhari S and Shahbazi A and Khodaei Ardakani MR and Rahmanzade R and Mehrabi S and Barati M and Joghataei MT}, title = {Effect of Bumetanide, a Selective Nkcc1 Inhibitor, on Hallucinations of Schizophrenic Patients; a Double-Blind Randomized Clinical Trial}, journal = {Schizophrenia Research}, volume = {184}, number = {}, pages = {145-146}, year = {2017} }
RIS	TY - JOUR AU - Rahmanzadeh R AU - Eftekhari S AU - Shahbazi A AU - Khodaei Ardakani MR AU - Rahmanzade R AU - Mehrabi S AU - Barati M AU - Joghataei MT TI - Effect of Bumetanide, a Selective Nkcc1 Inhibitor, on Hallucinations of Schizophrenic Patients; a Double-Blind Randomized Clinical Trial JO - Schizophrenia Research VL - 184 IS - SP - 145 EP - 146 PY - 2017 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract